The first human trial of a vaccine against Bundibugyo ebolavirus has launched, beginning recruitment, as an infected US patient has been admitted to a German hospital.

The first human trial of a vaccine against Bundibugyo ebolavirus has launched, beginning recruitment, as an infected US patient has been admitted to a German hospital. Link Oxford begins first human trial of Bundibugyo Ebola vaccine, Germany treats infected US citizen Recruitment for the vaccination trial has begun, with vaccinations expected to start in the coming weeks • US citizen becomes second to be treated in German hospital • Total DRC cases rise to 1,926